The global PTA Balloon Catheter Market size was valued at USD 2.4 billion in 2018 and is expected to register a CAGR of 10.1% over the forecast period. Rising prevalence of cardiovascular disorders and peripheral artery disease, growing geriatric population, and an increasing number of minimally invasive surgeries are some of the key factors boosting the market growth.
Cardiovascular diseases have become the leading cause of death worldwide in the past three decades. A sedentary lifestyle is one of the major causes leading to many chronic disorders such as diabetes and cardiovascular ailments. Harmful habits such as lack of physical activity, consumption of alcohol and unhealthy food, and smoking have resulted in a growing prevalence of obesity, which in turn, leads to various cardiovascular diseases. Surgical intervention for the treatment of such disorders has increased demand for percutaneous transluminal angioplasty (PTA) balloon catheter. According to a research article published by the NCBI in 2018, more than 200 million people suffer from Peripheral Artery Disease (PAD) across the globe. Individuals suffering from PAD are at a higher risk of developing severe heart conditions in the later stages of life. Rising hospitalization with an increase in cardiovascular disorders is expected to increase the adoption of PTA Balloon Catheter.
Treatment of PAD majorly includes minimally invasive procedures that involve the use of catheters to clear blocked arteries. Growing demand for angioplasty over conventional surgeries due to its minimally invasive nature and better outcomes has gained significant preference among patients. Minimally invasive procedures have led to an increase in the number of catheterization laboratories. Peripheral angioplasty is the most common minimally invasive procedure preferred by PAD-affected patients. These procedures are performed in a cardiovascular catheterization laboratory, under local anesthesia. The paradigm shift from conventional surgeries to angioplasty has led to an increase in sales of catheters, including PTA variants. These procedures have higher adoption rates and are becoming standard techniques in general surgery due to the use of advanced technologies and the availability of innovative coated PTA Balloon Catheter in the market.
However, catheters are often associated with vein thrombosis, which may lead to pulmonary embolism and, in some cases, may prove to be fatal. Thrombosis can result in obstruction of a catheter, which includes a ï¬brin sheath around the intraluminal, venous, mural thrombosis at the catheter tip. Patients who undergo cardiac catheterization are at a higher risk of catheter-associated bloodstream infections due to repeated use of catheters. According to a research article published by the NCBI in 2018, some of the major risks associated with cardiac catheterization are myocardial infarction, pseudoaneurysm, arteriovenous fistula, hematoma/retroperitoneal bleeding, thrombosis and embolism, and allergic reactions. Therefore, risks and complications associated with catheters may impede the growth of the market for PTA Balloon Catheters in the coming years. However, they can be overcome with technological advancements.
The global PTA Balloon Catheter Market has been segmented on the basis of region into North America, Europe, Asia Pacific, Latin America, and MEA. North America held the largest revenue share of 35.6% in 2018. This can be attributed to factors such as the presence of a large number of PTA balloon catheter manufacturers, suppliers, and distributors, high prevalence of cardiovascular disorders, presence of sophisticated healthcare infrastructure, and an increase in patient awareness about emerging minimally invasive surgeries in the region. In addition, growing preference for minimally invasive surgeries, such as minimally invasive coronary bypass and Minimally Invasive Cardiothoracic Surgery (MICS), is contributing to market growth in North America.
Asia Pacific is projected to register the fastest growth over the course of the forecast period to account for 23.0% of the revenue in 2026. This growth will be fueled by rising consumer awareness about emerging healthcare developments, increasing disposable income, and the presence of untapped opportunities for market players. Companies have the chance to focus on areas such as the development of PTA Balloon Catheter that can reduce catheters-associated risks. Apart from this, rapidly improving economic conditions in emerging countries such as India and China will also benefit market growth. In addition, the booming medical tourism industry and the market for medical devices are expected to have a positive impact on the APAC market.
Key players operating in the market for PTA Balloon Catheter are Medtronic plc; Terumo Corporation; Cardinal Health; Boston Scientific Corporation; Natec Medical; and Surmodics, Inc. Market players are focusing on strategically acquiring local players. For instance, in January 2016, Surmodics acquired NorMedix to strengthen its R&D capabilities and vascular device expertise. Geographical expansion is also seen as one of the strategic initiatives opted by key players in the market for PTA Balloon Catheter. For instance, in October 2017, Medtronic set up the Chengdu Innovation Center in China to facilitate training for local physicians to improve healthcare efficiency in Central and Western China.
Report Attribute |
Details |
Market size value in 2020 |
USD 2.8 billion |
Revenue forecast in 2026 |
USD 5.1 billion |
Growth Rate |
CAGR of 10.1% from 2019 to 2026 |
Base year for estimation |
2018 |
Historical data |
2015 - 2017 |
Forecast period |
2019 - 2026 |
Quantitative units |
Revenue in USD million and CAGR from 2019 to 2026 |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors and trends |
Segments covered |
Region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country scope |
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Japan; China; India; Australia; Brazil; Mexico; Argentina; Saudi Arabia; South Africa |
Key companies profiled |
Medtronic plc; Terumo Corporation; Cardinal Health; Boston Scientific Corporation; Natec Medical; Surmodics, Inc |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis on latest industry trends in each of the sub-segments from 2015 to 2026. For the purpose of this study, Grand View Research has segmented the global PTA Balloon Catheter Market report on the basis of region:
Regional Outlook (USD Million, 2015 - 2026)
North America
The U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Asia Pacific
Japan
China
India
Australia
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Saudi Arabia
South Africa
b. The global PTA balloon catheter market size was estimated at USD 2.5 billion in 2019 and is expected to reach USD 2.8 billion in 2020
b. The global PTA balloon catheter market is expected to grow at a compound annual growth rate of 10% from 2019 to 2027 to reach USD 5.5 billion by 2027
b. North America dominated the PTA balloon catheter market with a share of 35.6% in 2019. The presence of advanced healthcare infrastructure, rising incidence of PAD, and the presence of well-established manufacturers of PTA catheters are some of the key factors boosting the market growth.
b. Some key players operating in the PTA balloon catheter market include Medtronic plc; Terumo Corporation; Cardinal Health; Boston Scientific Corporation; Natec Medical; and Surmodics, Inc
b. Key factors that are driving the PTA balloon catheter market growth include the rising prevalence of cardiovascular diseases, the growing geriatric population, and an increasing number of minimally invasive surgeries.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.
"The quality of research they have done for us has been excellent."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.
We value your investment and offer free customization with every report to fulfil your exact research needs.